{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:26:45Z","timestamp":1780579605945,"version":"3.54.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T00:00:00Z","timestamp":1305676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1747-597x-6-9","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T06:49:29Z","timestamp":1308638969000},"source":"Crossref","is-referenced-by-count":40,"title":["There is no age limit for methadone: a retrospective cohort study"],"prefix":"10.1186","volume":"6","author":[{"given":"Kenneth M","family":"D\u00fcrsteler-MacFarland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard A","family":"Wiesbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie A","family":"Petitjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,18]]},"reference":[{"key":"161_CR1","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/S0140-6736(06)68804-1","volume":"367","author":"C Nordt","year":"2006","unstructured":"Nordt C, Stohler R: Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet. 2006, 367: 1830-1834. 10.1016\/S0140-6736(06)68804-1.","journal-title":"Lancet"},{"key":"161_CR2","volume-title":"Annual report","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2010","unstructured":"European Monitoring Centre for Drugs and Drug Addiction: Annual report. 2010, Luxembourg: Publications Office of the European Union; 2010, : the state of the drugs problem in Europe"},{"key":"161_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","volume":"58","author":"YI Hser","year":"2001","unstructured":"Hser YI, Hoffman V, Grella CE, Anglin MD: A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001, 58: 503-508. 10.1001\/archpsyc.58.5.503.","journal-title":"Arch Gen Psychiatry"},{"key":"161_CR4","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","volume":"280","author":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","year":"1998","unstructured":"National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction: Effective Medical Treatment of Opiate Addiction. JAMA. 1998, 280: 1936-1943. 10.1001\/jama.280.22.1936.","journal-title":"JAMA"},{"key":"161_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","volume":"353","author":"J Ward","year":"1999","unstructured":"Ward J, Hall W, Mattick RP: Role of maintenance treatment in opioid dependence. Lancet. 1999, 353: 221-226. 10.1016\/S0140-6736(98)05356-2.","journal-title":"Lancet"},{"key":"161_CR6","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1360-0443.2005.001128.x","volume":"100","author":"H Eder","year":"2005","unstructured":"Eder H, Jagsch R, Kraigher D, Primorac A, Ebner N, Fischer G: Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction. 2005, 100: 1101-1109. 10.1111\/j.1360-0443.2005.001128.x.","journal-title":"Addiction"},{"key":"161_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0740-5472(02)00259-3","volume":"23","author":"MJ Kreek","year":"2002","unstructured":"Kreek MJ, Vocci FJ: History and current status of opioid maintenance treatments: blending conference session. J Subst Abuse Treat. 2002, 23: 93-105. 10.1016\/S0740-5472(02)00259-3.","journal-title":"J Subst Abuse Treat"},{"key":"161_CR8","volume-title":"The Treatment of Opioid Dependence","author":"EC Strain","year":"2006","unstructured":"Strain EC, Stitzer ML: The Treatment of Opioid Dependence. 2006, Baltimore: Johns Hopkins University Press"},{"key":"161_CR9","first-page":"62","volume":"68","author":"S Magura","year":"2001","unstructured":"Magura S, Rosenblum A: Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001, 68: 62-74.","journal-title":"Mt Sinai J Med"},{"key":"161_CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/070674370605101003","volume":"51","author":"W Van den Brink","year":"2006","unstructured":"Van den Brink W, Haasen C: Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry. 2006, 51: 635-646.","journal-title":"Can J Psychiatry"},{"key":"161_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","volume":"193","author":"VP Dole","year":"1965","unstructured":"Dole VP, Nyswander ME: A medical treatment for diacetylmorphine (heroin) addiction. Journal of the American Medical Association. 1965, 193: 646-650.","journal-title":"Journal of the American Medical Association"},{"key":"161_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00213-002-1027-0","volume":"161","author":"EC Donny","year":"2002","unstructured":"Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML: High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology (Berl). 2002, 161: 202-212. 10.1007\/s00213-002-1027-0.","journal-title":"Psychopharmacology (Berl)"},{"key":"161_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-9089-3","volume-title":"The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome","author":"JC Ball","year":"1991","unstructured":"Ball JC, Ross A: The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. 1991, New York: Springer Verlag"},{"key":"161_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","volume":"93","author":"LA Marsch","year":"1998","unstructured":"Marsch LA: The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998, 93: 515-532. 10.1046\/j.1360-0443.1998.9345157.x.","journal-title":"Addiction"},{"key":"161_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2105\/AJPH.90.7.1100","volume":"90","author":"GS Zaric","year":"2000","unstructured":"Zaric GS, Barnett PG, Brandeau ML: HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health. 2000, 90: 1100-1111. 10.2105\/AJPH.90.7.1100.","journal-title":"Am J Public Health"},{"key":"161_CR16","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1001\/jama.282.14.1314","volume":"282","author":"AI Leshner","year":"1999","unstructured":"Leshner AI: Science-based views of drug addiction and its treatment. JAMA. 1999, 282: 1314-1316. 10.1001\/jama.282.14.1314.","journal-title":"JAMA"},{"key":"161_CR17","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1001\/jama.1993.03500150065028","volume":"269","author":"AT McLellan","year":"1993","unstructured":"McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP: The effects of psychosocial services in substance abuse treatment. JAMA. 1993, 269: 1953-1959. 10.1001\/jama.269.15.1953.","journal-title":"JAMA"},{"key":"161_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/00019442-200409000-00015","volume":"12","author":"S Firoz","year":"2004","unstructured":"Firoz S, Carlson G: Characteristics and treatment outcome of older methadone-maintenance patients. Am J Geriatr Psychiatry. 2004, 12: 539-541.","journal-title":"Am J Geriatr Psychiatry"},{"key":"161_CR19","first-page":"340","volume":"67","author":"B Frank","year":"2000","unstructured":"Frank B: An overview of heroin trends in New York City: past, present and future. Mt Sinai J Med. 2000, 67: 340-346.","journal-title":"Mt Sinai J Med"},{"key":"161_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jsat.2005.01.007","volume":"28","author":"MR Lofwall","year":"2005","unstructured":"Lofwall MR, Brooner RK, Bigelow GE, Kindbom K, Strain EC: Characteristics of older opioid maintenance patients. J Subst Abuse Treat. 2005, 28: 265-272. 10.1016\/j.jsat.2005.01.007.","journal-title":"J Subst Abuse Treat"},{"key":"161_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/geront\/44.4.543","volume":"44","author":"D Rosen","year":"2004","unstructured":"Rosen D: Factors associated with illegal drug use among older methadone clients. Gerontologist. 2004, 44: 543-547.","journal-title":"Gerontologist"},{"key":"161_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1525-8610(04)70283-2","volume":"4","author":"RJ Goldberg","year":"2003","unstructured":"Goldberg RJ, Grabowski R: Methadone maintenance: its future in skilled nursing facilities. J Am Med Dir Assoc. 2003, 4: 98-100. 10.1016\/S1525-8610(04)70283-2.","journal-title":"J Am Med Dir Assoc"},{"key":"161_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10865-004-0005-x","volume":"27","author":"YI Hser","year":"2004","unstructured":"Hser YI, Gelberg L, Hoffman V, Grella CE, McCarthy W, Anglin MD: Health conditions among aging narcotics addicts: medical examination results. J Behav Med. 2004, 27: 607-622. 10.1007\/s10865-004-0005-x.","journal-title":"J Behav Med"},{"key":"161_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5055\/jom.2009.0004","volume":"5","author":"R Rajaratnam","year":"2009","unstructured":"Rajaratnam R, Sivesind D, Todman M, Roane D, Seewald R: The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life. J Opioid Manag. 2009, 5: 27-37.","journal-title":"J Opioid Manag"},{"key":"161_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/JGP.0b013e31816ff35a","volume":"16","author":"D Rosen","year":"2008","unstructured":"Rosen D, Smith ML, Reynolds CFr: The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry. 2008, 16: 488-497. 10.1097\/JGP.0b013e31816ff35a.","journal-title":"Am J Geriatr Psychiatry"},{"key":"161_CR26","unstructured":"Arndt S, Clayton R, Schultz SK: Trends in substance abuse treatment 1998-2008: increasing older adult first-time admissions for illicit drugs. Am J Geriatr Psychiatry."},{"key":"161_CR27","first-page":"4","volume":"12","author":"Addiction Treatment Forum","year":"2003","unstructured":"Addiction Treatment Forum: Current comments - the further \u201egraying of methadone\". Addiction Treatment Forum. 2003, 12: 4-5.","journal-title":"Addiction Treatment Forum"},{"key":"161_CR28","volume-title":"Methadone maintenance treatment in general practice or in specialized centers: profile and outcomes of patients in the Swiss canton of Basle","author":"S Petitjean","year":"2010","unstructured":"Petitjean S: Methadone maintenance treatment in general practice or in specialized centers: profile and outcomes of patients in the Swiss canton of Basle. 2010, Lengerich: Pabst Science Publishers"},{"key":"161_CR29","unstructured":"Swiss Federal Office of Public Health: Nationale Methadonstatistik [National statistics of methadone substitution treatment]. http:\/\/www.bag.admin.ch\/themen\/drogen\/00042\/00632\/03383\/index.html?lang=fr"},{"key":"161_CR30","unstructured":"Swiss Society of Addiction Medicine (SSAM): Clinical recommendations for substitution-assisted treatment in opioid dependence. http:\/\/www.ssam.ch\/SSAM\/de\/Substitutionsempfehlungen"},{"key":"161_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1747-597X-4-14","volume":"4","author":"C Nordt","year":"2009","unstructured":"Nordt C, Landolt K, Stohler R: Estimating incidence trends in regular heroin use in 26 regions of Switzerland using methadone treatment data. Subst Abuse Treat Prev Policy. 2009, 4: 14-10.1186\/1747-597X-4-14.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"161_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000070984","volume":"9","author":"V Maag","year":"2003","unstructured":"Maag V: Estimated trends in the prevalence of heroin addiction in Switzerland. A multiple-indicator approach. Eur Addict Res. 2003, 9: 176-181. 10.1159\/000070984.","journal-title":"Eur Addict Res"},{"key":"161_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2710.2006.00767.x","volume":"31","author":"GL Dickinson","year":"2006","unstructured":"Dickinson GL, Rostami-Hodjegan A, Lagundoye O, Seivewright N, Pratt P, Lennard MS: A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK. J Clin Pharm Ther. 2006, 31: 477-484. 10.1111\/j.1365-2710.2006.00767.x.","journal-title":"J Clin Pharm Ther"},{"key":"161_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.drugalcdep.2005.09.004","volume":"82","author":"E Peles","year":"2006","unstructured":"Peles E, Schreiber S, Adelson M: Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend. 2006, 82: 211-217. 10.1016\/j.drugalcdep.2005.09.004.","journal-title":"Drug Alcohol Depend"},{"key":"161_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.11.020","volume":"83","author":"SW Villafranca","year":"2006","unstructured":"Villafranca SW, McKellar JD, Trafton JA, Humphreys K: Predictors of retention in methadone programs: A signal detection analysis. Drug Alcohol Depend. 2006, 83: 218-224. 10.1016\/j.drugalcdep.2005.11.020.","journal-title":"Drug Alcohol Depend"},{"key":"161_CR36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF03405776","volume":"95","author":"JF Anderson","year":"2004","unstructured":"Anderson JF, Warren LD: Client retention in the British Columbia Methadone Program, 1996-1999. Can J Public Health. 2004, 95: 104-109.","journal-title":"Can J Public Health"},{"key":"161_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0376-8716(98)00091-X","volume":"52","author":"D D'Ippoliti","year":"1998","unstructured":"D'Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bargagli AM: Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage. Drug Alcohol Depend. 1998, 52: 167-171. 10.1016\/S0376-8716(98)00091-X.","journal-title":"Drug Alcohol Depend"},{"key":"161_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0376-8716(99)00088-5","volume":"57","author":"GW Joe","year":"1999","unstructured":"Joe GW, Simpson DD, Broome KM: Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend. 1999, 57: 113-125. 10.1016\/S0376-8716(99)00088-5.","journal-title":"Drug Alcohol Depend"},{"key":"161_CR39","first-page":"276","volume":"49","author":"R Stohler","year":"2004","unstructured":"Stohler R, Nordt C, Falcato L, D\u00fcrsteler-MacFarland K, R\u00f6ssler W: Effektive Methadonbehandlungen: Vergleich der Behandlungsdauer in spezialisierten Institutionen und Privatpraxen [Is methadone maintenance provided by private practitioners effective?]. Soz Praventivmed. 2004, 49: 276-280.","journal-title":"Soz Praventivmed"},{"key":"161_CR40","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1176\/appi.ajp.162.8.1494","volume":"162","author":"WM Compton","year":"2005","unstructured":"Compton WM, Thomas YF, Conway KP, Colliver JD: Developments in the epidemiology of drug use and drug use disorders. Am J Psychiatry. 2005, 162: 1494-1502. 10.1176\/appi.ajp.162.8.1494.","journal-title":"Am J Psychiatry"},{"key":"161_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.drugalcdep.2008.03.028","volume":"97","author":"BD Marshall","year":"2008","unstructured":"Marshall BD, Fairbairn N, Li K, Wood E, Kerr T: Physical violence among a prospective cohort of injection drug users: a gender-focused approach. Drug Alcohol Depend. 2008, 97: 237-246. 10.1016\/j.drugalcdep.2008.03.028.","journal-title":"Drug Alcohol Depend"},{"key":"161_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.annepidem.2008.12.007","volume":"19","author":"LA Simmons","year":"2009","unstructured":"Simmons LA, Havens JR, Whiting JB, Holz JL, Bada H: Illicit drug use among women with children in the United States: 2002-2003. Ann Epidemiol. 2009, 19: 187-193. 10.1016\/j.annepidem.2008.12.007.","journal-title":"Ann Epidemiol"},{"key":"161_CR43","first-page":"804","volume":"45","author":"H Balthasar","year":"2007","unstructured":"Balthasar H, Huissoud T, Zobel F, Arnaud S, Samitca S, Jeannin A, Schnoz D, Gervasoni JP, Dubois-Arber F: Entwicklung des Konsums und des Risikoverhaltens bez\u00fcglich HIV- und HCV-\u00dcbertragung bei Drogen injizierenden Personen in der Schweiz, 1993-2006 [Development of use and risk behaviour concerning transmission of HIV and HCV in drug-injecting persons in Switzerland, 1993-2006]. Bulletin - BAG. 2007, 45: 804-809.","journal-title":"Bulletin - BAG"},{"key":"161_CR44","volume-title":"World Drug Report","author":"UNODC","year":"2004","unstructured":"UNODC: World Drug Report. 2004, Vienna; 2004"},{"key":"161_CR45","first-page":"13","volume":"6","author":"V Maag","year":"2006","unstructured":"Maag V: Kokain - die neue Volksdroge? Nationale und internationale Trends [Cocaine--the new \"people's drug\"? National and international trends]. Abh\u00e4ngigkeiten. 2006, 6: 13-22.","journal-title":"Abh\u00e4ngigkeiten"},{"key":"161_CR46","volume-title":"Immunity & Ageing","author":"AS Reece","year":"2007","unstructured":"Reece AS: Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immunity & Ageing. 2007, 4:"},{"key":"161_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/01.pra.0000351884.83377.e2","volume":"15","author":"A Fareed","year":"2009","unstructured":"Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K: Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. J Psychiatr Pract. 2009, 15: 227-234. 10.1097\/01.pra.0000351884.83377.e2.","journal-title":"J Psychiatr Pract"},{"key":"161_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.drugpo.2010.01.012","volume":"21","author":"C Beynon","year":"2010","unstructured":"Beynon C, McVeigh J, Hurst A, Marr A: Older and sicker: Changing mortality of drug users in treatment in the North West of England. Int J Drug Policy. 2010, 21: 429-431. 10.1016\/j.drugpo.2010.01.012.","journal-title":"Int J Drug Policy"},{"key":"161_CR49","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/15332560802157065","volume":"8","author":"KO Conner","year":"2008","unstructured":"Conner KO, Rosen D: \"You're nothing but a junkie\": The multiple experiences of stigma in an aging methadone maintenance population. Journal of Social Work Practice in the Addictions. 2008, 8: 244-264. 10.1080\/15332560802157065.","journal-title":"Journal of Social Work Practice in the Addictions"},{"key":"161_CR50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1046\/j.1360-0443.2003.00388.x","volume":"98","author":"TL Anderson","year":"2003","unstructured":"Anderson TL, Levy JA: Marginality among older injectors in today's illicit drug culture: assessing the impact of ageing. Addiction. 2003, 98: 761-770. 10.1046\/j.1360-0443.2003.00388.x.","journal-title":"Addiction"},{"key":"161_CR51","doi-asserted-by":"publisher","first-page":"520","DOI":"10.15288\/jsa.2003.64.520","volume":"64","author":"DD Satre","year":"2003","unstructured":"Satre DD, Mertens J, Arean PA, Weisner C: Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program. J Stud Alcohol. 2003, 64: 520-530.","journal-title":"J Stud Alcohol"},{"key":"161_CR52","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jsat.2010.09.003","volume":"40","author":"D Rosen","year":"2011","unstructured":"Rosen D, Morse JQ, Reynolds CF: Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment. J Subst Abuse Treat. 2011, 40: 132-141. 10.1016\/j.jsat.2010.09.003.","journal-title":"J Subst Abuse Treat"},{"key":"161_CR53","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1360-0443.2009.02633.x","volume":"104","author":"L Burns","year":"2009","unstructured":"Burns L, Randall D, Hall WD, Law M, Butler T, Bell J, Degenhardt L: Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction. 2009, 104: 1363-1372. 10.1111\/j.1360-0443.2009.02633.x.","journal-title":"Addiction"},{"key":"161_CR54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1176\/appi.ajp.2007.07121944","volume":"165","author":"B Adinoff","year":"2008","unstructured":"Adinoff B: Divided doses for methadone maintenance. Am J Psychiatry. 2008, 165: 303-305. 10.1176\/appi.ajp.2007.07121944.","journal-title":"Am J Psychiatry"},{"key":"161_CR55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.05.027","volume":"85","author":"TW Kim","year":"2006","unstructured":"Kim TW, Alford DP, Malabanan A, Holick MF, Samet JH: Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend. 2006, 85: 258-262. 10.1016\/j.drugalcdep.2006.05.027.","journal-title":"Drug Alcohol Depend"},{"key":"161_CR56","first-page":"374","volume-title":"Clinical Textbook of Addictive Disorders","author":"R Abrams","year":"1998","unstructured":"Abrams R, Alexopoulos G: Geriatric addictions. Clinical Textbook of Addictive Disorders. Edited by: Frances R, Miller S. 1998, New York: Guilford, 374-396. 2","edition":"2"},{"key":"161_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.drugalcdep.2005.07.004","volume":"81","author":"KM Dursteler-MacFarland","year":"2006","unstructured":"Dursteler-MacFarland KM, Stohler R, Moldovanyi A, Rey S, Basdekis R, Gschwend P, Eschmann S, Rehm J: Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine. Drug Alcohol Depend. 2006, 81: 231-239. 10.1016\/j.drugalcdep.2005.07.004.","journal-title":"Drug Alcohol Depend"},{"key":"161_CR58","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00228-007-0327-z","volume":"63","author":"S Bomsien","year":"2007","unstructured":"Bomsien S, Skopp G: An in vitro approach to potential methadone metabolic-inhibition interactions. Eur J Clin Pharmacol. 2007, 63: 821-827. 10.1007\/s00228-007-0327-z.","journal-title":"Eur J Clin Pharmacol"},{"key":"161_CR59","first-page":"19","volume":"1","author":"CB Eap","year":"1999","unstructured":"Eap CB, D\u00e9glon J-J, Baumann P: Pharmacokinetics and pharmacogenetics of methadone: clinical relevance. Heroin Add & Rel Clin Probl. 1999, 1: 19-34.","journal-title":"Heroin Add & Rel Clin Probl"},{"key":"161_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1056-8719(00)00043-5","volume":"42","author":"MJ Garrido","year":"1999","unstructured":"Garrido MJ, Troconiz IF: Methadone: a review of its pharmacokinetic\/pharmacodynamic properties. J Pharmacol Toxicol Methods. 1999, 42: 61-66. 10.1016\/S1056-8719(00)00043-5.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"161_CR61","first-page":"231","volume":"20","author":"A Nicak","year":"1978","unstructured":"Nicak A, Kohut A: Development of tolerance to morphine and pethidine in rats in dependence on age. Act Nerv Super (Praha). 1978, 20: 231-235.","journal-title":"Act Nerv Super (Praha)"},{"key":"161_CR62","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1213\/01.ANE.0000152191.29311.9B","volume":"100","author":"C Buntin-Mushock","year":"2005","unstructured":"Buntin-Mushock C, Phillip L, Moriyama K, Palmer PP: Age-dependent opioid escalation in chronic pain patients. Anesth Analg. 2005, 100: 1740-1745. 10.1213\/01.ANE.0000152191.29311.9B.","journal-title":"Anesth Analg"},{"key":"161_CR63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2296-10-42","volume":"10","author":"N Ryder","year":"2009","unstructured":"Ryder N, Cullen W, Barry J, Bury G, Keenan E, Smyth BP: Prevalence of problem alcohol use among patients attending primary care for methadone treatment. BMC Fam Pract. 2009, 10: 42-10.1186\/1471-2296-10-42.","journal-title":"BMC Fam Pract"},{"key":"161_CR64","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","volume":"94","author":"JM White","year":"1999","unstructured":"White JM, Irvine RJ: Mechanisms of fatal opioid overdose. Addiction. 1999, 94: 961-972. 10.1046\/j.1360-0443.1999.9479612.x.","journal-title":"Addiction"},{"key":"161_CR65","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/gme.0b013e31815879df","volume":"15","author":"TM Johnson","year":"2008","unstructured":"Johnson TM, Cohen HW, Howard AA, Santoro N, Floris-Moore M, Arnsten JH, Hartel DM, Schoenbaum EE: Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women. Menopause. 2008, 15: 551-557. 10.1097\/gme.0b013e31815879df.","journal-title":"Menopause"},{"key":"161_CR66","first-page":"839","volume":"35","author":"J Sherman","year":"2006","unstructured":"Sherman J: Women on methadone. Aust Fam Physician. 2006, 35: 839-author reply 839","journal-title":"Aust Fam Physician"},{"key":"161_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1300\/J010v45n04_03","volume":"45","author":"E Tuchman","year":"2007","unstructured":"Tuchman E: Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment. Soc Work Health Care. 2007, 45: 43-62.","journal-title":"Soc Work Health Care"},{"key":"161_CR68","first-page":"1","volume":"14","author":"C Winick","year":"1962","unstructured":"Winick C: Maturing out of narcotic addiction. United Nations Bulletin on Narcotics. 1962, 14: 1-7.","journal-title":"United Nations Bulletin on Narcotics"},{"key":"161_CR69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1600-0447.1988.tb05071.x","volume":"77","author":"S Haastrup","year":"1988","unstructured":"Haastrup S, Jepsen PW: Eleven year follow-up of 300 young opioid addicts. Acta Psychiatr Scand. 1988, 77: 22-26. 10.1111\/j.1600-0447.1988.tb05071.x.","journal-title":"Acta Psychiatr Scand"},{"key":"161_CR70","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","volume":"9","author":"DJ Weschules","year":"2008","unstructured":"Weschules DJ, Bain KT, Richeimer S: Actual and potential drug interactions associated with methadone. Pain Med. 2008, 9: 315-344. 10.1111\/j.1526-4637.2006.00289.x.","journal-title":"Pain Med"},{"key":"161_CR71","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1111\/j.1475-6773.2008.00870.x","volume":"43","author":"HA Pollack","year":"2008","unstructured":"Pollack HA, D'Aunno T: Dosage patterns in methadone treatment: results from a national survey, 1988-2005. Health Serv Res. 2008, 43: 2143-2163. 10.1111\/j.1475-6773.2008.00870.x.","journal-title":"Health Serv Res"},{"key":"161_CR72","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1360-0443.2007.01762.x","volume":"102","author":"J Strang","year":"2007","unstructured":"Strang J, Manning V, Mayet S, Ridge G, Best D, Sheridan J: Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005. Addiction. 2007, 102: 761-770. 10.1111\/j.1360-0443.2007.01762.x.","journal-title":"Addiction"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1747-597X-6-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1747-597X-6-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1747-597X-6-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T13:21:47Z","timestamp":1592659307000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/1747-597X-6-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,18]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1186\/1747-597x-6-9","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,18]]},"article-number":"9"}}